Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

723 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The immunobiology of cancer immunosurveillance and immunoediting.
Dunn GP, Old LJ, Schreiber RD. Dunn GP, et al. Among authors: old lj. Immunity. 2004 Aug;21(2):137-48. doi: 10.1016/j.immuni.2004.07.017. Immunity. 2004. PMID: 15308095 Review.
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
Bender A, Karbach J, Neumann A, Jäger D, Al-Batran SE, Atmaca A, Weidmann E, Biskamp M, Gnjatic S, Pan L, Hoffman E, Old LJ, Knuth A, Jäger E. Bender A, et al. Among authors: old lj. Cancer Immun. 2007 Oct 19;7:16. Cancer Immun. 2007. PMID: 17944437 Free PMC article. Clinical Trial.
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.
Uenaka A, Wada H, Isobe M, Saika T, Tsuji K, Sato E, Sato S, Noguchi Y, Kawabata R, Yasuda T, Doki Y, Kumon H, Iwatsuki K, Shiku H, Monden M, Jungbluth AA, Ritter G, Murphy R, Hoffman E, Old LJ, Nakayama E. Uenaka A, et al. Among authors: old lj. Cancer Immun. 2007 Apr 19;7:9. Cancer Immun. 2007. PMID: 17441676 Free PMC article. Clinical Trial.
NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.
Nakada T, Noguchi Y, Satoh S, Ono T, Saika T, Kurashige T, Gnjatic S, Ritter G, Chen YT, Stockert E, Nasu Y, Tsushima T, Kumon H, Old LJ, Nakayama E. Nakada T, et al. Among authors: old lj. Cancer Immun. 2003 Jul 31;3:10. Cancer Immun. 2003. PMID: 12889868
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
Jäger E, Karbach J, Gnjatic S, Jäger D, Maeurer M, Atmaca A, Arand M, Skipper J, Stockert E, Chen YT, Old LJ, Knuth A. Jäger E, et al. Among authors: old lj. Cancer Immun. 2002 Sep 19;2:12. Cancer Immun. 2002. PMID: 12747757
Cancer vaccines 2003: opening address.
Old LJ. Old LJ. Cancer Immun. 2003 Dec 12;3 Suppl 2:1. Epub 2003 Dec 12. Cancer Immun. 2003. PMID: 15022367 No abstract available.
Urine antibody against human cancer antigen NY-ESO-1.
Jäger D, Stockert E, Karbach J, Herrlinger K, Atmaca A, Arand M, Chen YT, Gnjatic S, Old LJ, Knuth A, Jäger E. Jäger D, et al. Among authors: old lj. Cancer Immun. 2002 Aug 6;2:10. Cancer Immun. 2002. PMID: 12747755
Cancer Vaccine Collaborative 2002: opening address.
Old LJ. Old LJ. Cancer Immun. 2003 Feb 6;3 Suppl 1:1. Cancer Immun. 2003. PMID: 12747742 No abstract available.
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.
Yuan J, Ku GY, Gallardo HF, Orlandi F, Manukian G, Rasalan TS, Xu Y, Li H, Vyas S, Mu Z, Chapman PB, Krown SE, Panageas K, Terzulli SL, Old LJ, Houghton AN, Wolchok JD. Yuan J, et al. Among authors: old lj. Cancer Immun. 2009 Jun 5;9:5. Cancer Immun. 2009. PMID: 19496531 Free PMC article. Clinical Trial.
Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2.
Zhuang R, Zhu Y, Fang L, Liu XS, Tian Y, Chen LH, Ouyang WM, Xu XG, Jian JL, Güre AO, Fortunato S, Ritter G, Old LJ, Simpson AJ, Chen YT, Jin B, Jungbluth AA. Zhuang R, et al. Among authors: old lj. Cancer Immun. 2006 Apr 5;6:7. Cancer Immun. 2006. PMID: 16594646
723 results
Jump to page
Feedback